Moneycontrol PRO
covid 19 vaccine
Jump to
  • Pfizer says COVID-19 vaccine will cost $110-$130 per dose Oct 21, 2022 10:36 PM IST

    Pfizer says COVID-19 vaccine will cost $110-$130 per dose

    More than 375 million doses of the original vaccine, which Pfizer developed with the German drugmaker BioNTech, have been distributed in the U.S., according to the Centers for Disease Control and Prevention.

  • Health Ministry to stop procuring fresh COVID-19 vaccines, surrenders Rs 4,237 crore from vaccination budget Oct 16, 2022 05:57 PM IST

    Health Ministry to stop procuring fresh COVID-19 vaccines, surrenders Rs 4,237 crore from vaccination budget

    According to the Ministry of Health and Family Welfare, 219.32 crore doses of the coronavirus vaccine have been administered to beneficiaries across the country so far.

  • Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO Sep 12, 2022 04:06 PM IST

    Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

    The managing director of vaccine manufacturing company says regulatory framework along with financing and market predictability are important bottlenecks in developing variant specific vaccines against evolving coronavirus

  • All about the world's first inhalable COVID-19 vaccine to get approval Sep 05, 2022 03:53 PM IST

    All about the world's first inhalable COVID-19 vaccine to get approval

    The vaccine has been approved by China. It is meant to be used as a booster dose.

  • In pics | All you need to know about BCG vaccine for TB that can protect humans from COVID-19 Aug 21, 2022 04:38 PM IST

    In pics | All you need to know about BCG vaccine for TB that can protect humans from COVID-19

    As per recent studies, the BCG vaccine -- originally for tuberculosis (TB), can provide protection against COVID-19, and several infections such as leprosy and malaria.

  • UK first to approve Omicron COVID shot with Moderna go-ahead Aug 15, 2022 06:26 PM IST

    UK first to approve Omicron COVID shot with Moderna go-ahead

    The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna conditional approval as a booster for adults on Monday.

  • Cumulative COVID-19 vaccine doses administered in India cross 208.21 crore-mark: Health ministry Aug 14, 2022 10:09 PM IST

    Cumulative COVID-19 vaccine doses administered in India cross 208.21 crore-mark: Health ministry

    Over 3.97 crore children in the age group of 12-14 years have been administered the first dose, while more than 6.14 crore adolescents in the age group 15-18 years have been given the first dose.

  • From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier Aug 10, 2022 07:01 PM IST

    From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier

    The recipients of Covaxin and Covishield, however, will also have an option of receiving the same vaccine they had taken for their primary vaccination

  • COVID-19 vaccines not effective without yoga, ayurveda, claims Ramdev Aug 04, 2022 10:48 PM IST

    COVID-19 vaccines not effective without yoga, ayurveda, claims Ramdev

    "Without the support of yoga and Ayurveda, no vaccine can immunise you permanently against coronavirus, no matter how big you are, a president or a big doctor yourself," the yoga guru said.

  • Ensure Sputnik V recipients take its 2nd, precaution doses: Centre to states Jul 14, 2022 07:23 PM IST

    Ensure Sputnik V recipients take its 2nd, precaution doses: Centre to states

    In a letter to states and Union Territories, Union Health Secretary Rajesh Bhushan on Thursday said it has been observed that the uptake of precaution dose of Sputnik V is only 0.5 per cent of those due for it.

  • Cabinet approves free booster COVID-19 vaccine dose for adults Jul 13, 2022 03:42 PM IST

    Cabinet approves free booster COVID-19 vaccine dose for adults

    Free booster doses of the COVID-19 vaccine will be available at public healthcare facilities for 75 days starting July 15.

  • Health Ministry reduces gap between second vaccine dose and booster dose Jul 06, 2022 05:42 PM IST

    Health Ministry reduces gap between second vaccine dose and booster dose

    The COVID-19 booster dose gap for adult beneficiaries in India has been lowered from the previously decided nine-month period to a six-month period by the Union Health Ministry. The National Technical Advisory Group on Immunization's advice served as the foundation for the decision.

  • mRNA booster shot in pipeline, says Gennova Biopharmaceuticals Jun 29, 2022 06:08 PM IST

    mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

    After getting the nod from India's drug regulator, Gennova Biopharmaceuticals is now aiming for WHO approval for its mRNA vaccine

  • US rolls out COVID-19 vaccines for children under five Jun 23, 2022 01:14 PM IST

    US rolls out COVID-19 vaccines for children under five

    The United States has delivered about 2.7 million doses of COVID vaccines for children below five years to administration centres while another one million shots will reach the sites soon, the Department of Health and Human Services said on June 22.

  • Paraguay cancels order for one million Covaxin doses citing quality issues: Reports Jun 07, 2022 11:03 PM IST

    Paraguay cancels order for one million Covaxin doses citing quality issues: Reports

    Bharat Biotech did not immediately react to the development, but company sources reportedly said that all export orders already stand cancelled as the production has been halted.

  • FDA advisers meeting on Novavax, a latecomer in vaccine race Jun 07, 2022 06:53 PM IST

    FDA advisers meeting on Novavax, a latecomer in vaccine race

    A federal advisory committee Tuesday will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.

  • Pfizer to offer low-cost medicines, vaccines to world's poorest countries May 25, 2022 12:42 PM IST

    Pfizer to offer low-cost medicines, vaccines to world's poorest countries

    US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs at a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.

  • Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5 May 23, 2022 09:17 PM IST

    Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5

    Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

  • The COVID pandemic is ‘most certainly not over’: WHO chief Tedros Adhanom Ghebreyesus May 23, 2022 05:09 PM IST

    The COVID pandemic is ‘most certainly not over’: WHO chief Tedros Adhanom Ghebreyesus

    The UN health agency’s director-general, Tedros Adhanom Ghebreyesus, told officials gathered in Geneva for opening of the WHO’s annual meeting that “declining testing and sequencing means we are blinding ourselves to the evolution of the virus.” He also noted that almost 1 billion people in lower-income countries still haven’t been vaccinated.

  • Pfizer/BioNTech say 3 COVID shots generate good response in under-5s May 23, 2022 04:42 PM IST

    Pfizer/BioNTech say 3 COVID shots generate good response in under-5s

    The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group, children for whom no vaccine is currently approved in most of the world.

  • AstraZeneca's COVID jab Vaxzevria wins EU approval as booster May 23, 2022 02:30 PM IST

    AstraZeneca's COVID jab Vaxzevria wins EU approval as booster

    "Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine."

  • Over 191.91 crore COVID vaccine doses administered in India: Govt May 20, 2022 06:44 AM IST

    Over 191.91 crore COVID vaccine doses administered in India: Govt

    A total of 47,761 precaution doses of COVID-19 vaccine were administered to beneficiaries aged 18-59 years till 7 pm, taking the total number of such doses given in this age-group to 16,25,744 so far, according to the ministry’s data.

  • US CDC urges Pfizer booster for children ages 5 to 11 May 20, 2022 06:23 AM IST

    US CDC urges Pfizer booster for children ages 5 to 11

    Pfizer and its partner BioNTech currently make the only COVID-19 vaccine available for children of any age in the U.S. Those ages 5 to 11 receive a dose that’s one-third the amount given to everyone 12 and older.

  • WHO authorises China's CanSinoBIO COVID-19 vaccine May 19, 2022 05:23 PM IST

    WHO authorises China's CanSinoBIO COVID-19 vaccine

    "The vaccine meets WHO standards for protection against Covid-19 and... the benefits of the vaccine far outweigh risks," the UN health agency said in a statement.

  • US FDA authorizes Pfizer's COVID booster shot for young children May 17, 2022 08:22 PM IST

    US FDA authorizes Pfizer's COVID booster shot for young children

    The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine.